Esperion Therapeutics (ESPR) Fails to deliver data

Key failure to deliver metrics for Esperion Therapeutics:

• Last SEC data release: 2026-01-30
• Last 15 days FTD volume: ₹0.68 M
• Last 3 months FTD volume: ₹3.5 M
• Last 12 months FTD volume: ₹7.97 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Esperion Therapeutics (ESPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Esperion Therapeutics (ESPR) - since 2013

Esperion Therapeutics (ESPR) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	₹61.7 M	₹0.13 B	🇺🇸 USA
Regeneron Pharmaceuticals REGN	₹2.75 M	₹61.72 M	🇺🇸 USA
Ultragenyx Pharmaceutical RARE	₹3.65 M	₹9.37 M	🇺🇸 USA
Lexicon Pharmaceuticals LXRX	₹1.32 M	₹11.93 M	🇺🇸 USA
Amicus Therapeutics FOLD	₹7.23 M	₹20.57 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	₹8.07 M	₹14.34 M	🇺🇸 USA